CLINICAL_TRIALS
trial_result
· 2012-10-25
Clinical Trial Update: Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma [Phase 3]
Summary
A Phase 3 trial evaluating interferon plus temsirolimus (CCI-779) in advanced renal cell carcinoma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell, Kidney Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2012-10-25